Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

KRN-5500 shows significant activity against CLL cells in vitro

Aug. 28, 2003

Novel telomerase inhibitors covered by Cancer Research Technology patent

Aug. 27, 2003

Approval for pediatric extension of Fludara

Aug. 26, 2003

Approvable letter for Zometa for patients with bone metastases from advanced cancer

Aug. 26, 2003

Effect of DN-101 on chemotherapy for NSCLC evaluated in new phase I/II trial

Aug. 26, 2003

Cytochroma discovers new retinoic acid metabolizing cytochrome P450

Aug. 26, 2003

Good toxicity profile reported for squalamine in patients with solid tumors

Aug. 26, 2003

Local methotrexate reported to inhibit tumor progression in mice

Aug. 26, 2003

New alphavbeta3/alphavbeta5 antagonists prepared and tested at Bayer

Aug. 25, 2003

Thalidomide recommended for approval in Australia

Aug. 25, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...